健康与疾病状态下铁代谢概述。
Overview of iron metabolism in health and disease.
作者信息
Dev Som, Babitt Jodie L
机构信息
Division of Nephrology, Program in Membrane Biology, Center for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
出版信息
Hemodial Int. 2017 Jun;21 Suppl 1(Suppl 1):S6-S20. doi: 10.1111/hdi.12542. Epub 2017 Mar 15.
Abstract
Iron is an essential element for numerous fundamental biologic processes, but excess iron is toxic. Abnormalities in systemic iron balance are common in patients with chronic kidney disease and iron administration is a mainstay of anemia management in many patients. This review provides an overview of the essential role of iron in biology, the regulation of systemic and cellular iron homeostasis, how imbalances in iron homeostasis contribute to disease, and the implications for chronic kidney disease patients.
摘要
铁是众多基本生物过程所必需的元素，但铁过量具有毒性。慢性肾脏病患者常出现全身铁平衡异常，在许多患者中，铁剂给药是贫血管理的主要手段。本综述概述了铁在生物学中的重要作用、全身和细胞铁稳态的调节、铁稳态失衡如何导致疾病以及对慢性肾脏病患者的影响。
相似文献
1
Overview of iron metabolism in health and disease.健康与疾病状态下铁代谢概述。
Hemodial Int. 2017 Jun;21 Suppl 1(Suppl 1):S6-S20. doi: 10.1111/hdi.12542. Epub 2017 Mar 15.
2
Iron metabolism: iron deficiency and iron overload.铁代谢：缺铁与铁过载。
Annu Rev Genomics Hum Genet. 2000;1:75-98. doi: 10.1146/annurev.genom.1.1.75.
3
The Case for an Estrogen-iron Axis in Health and Disease.健康与疾病中雌激素-铁轴的情况
Exp Clin Endocrinol Diabetes. 2020 Apr;128(4):270-277. doi: 10.1055/a-0885-1677. Epub 2019 Apr 12.
4
[Iron deficiency and overload. Implications in oxidative stress and cardiovascular health].[缺铁与铁过载。对氧化应激和心血管健康的影响]
Nutr Hosp. 2010 May-Jun;25(3):350-65.
5
Disorders of Iron Metabolism and Anemia in Chronic Kidney Disease.慢性肾脏病中的铁代谢紊乱与贫血
Semin Nephrol. 2016 Jul;36(4):252-61. doi: 10.1016/j.semnephrol.2016.05.002.
6
Role of Iron in the Molecular Pathogenesis of Diseases and Therapeutic Opportunities.铁在疾病的分子发病机制中的作用及治疗机会。
ACS Chem Biol. 2021 Jun 18;16(6):945-972. doi: 10.1021/acschembio.1c00122. Epub 2021 Jun 9.
7
Iron: effect of overload and deficiency.铁：过载与缺乏的影响
Met Ions Life Sci. 2013;13:229-94. doi: 10.1007/978-94-007-7500-8_8.
8
Iron homeostasis in the liver.肝脏中的铁稳态。
Compr Physiol. 2013 Jan;3(1):315-30. doi: 10.1002/cphy.c120016.
9
Iron Balance and the Role of Hepcidin in Chronic Kidney Disease.铁平衡与铁调素在慢性肾脏病中的作用
Semin Nephrol. 2016 Mar;36(2):87-93. doi: 10.1016/j.semnephrol.2016.02.001.
10
Dysregulation of iron metabolism in cardiovascular diseases: From iron deficiency to iron overload.心血管疾病中铁代谢的失调：从缺铁到铁过载。
Biochem Pharmacol. 2021 Aug;190:114661. doi: 10.1016/j.bcp.2021.114661. Epub 2021 Jun 23.
引用本文的文献
1
Iron Overload Accelerates Aging-Associated Kidney Injury in Mice: Implications for Iron Supplementation in the Elderly.铁过载加速小鼠衰老相关的肾损伤：对老年人补铁的启示。
Nutrients. 2025 Aug 8;17(16):2580. doi: 10.3390/nu17162580.
2
TIPE2 suppresses ferroptosis and pro-inflammatory polarization in macrophages triggered by SARS-CoV-2 spike protein.TIPE2抑制由SARS-CoV-2刺突蛋白触发的巨噬细胞铁死亡和促炎极化。
Sci Rep. 2025 Aug 18;15(1):30246. doi: 10.1038/s41598-025-14235-1.
3
Structural characteristics, multifunctional applications, and research prospects of ferritin: a case study of sturgeon ferritin.铁蛋白的结构特征、多功能应用及研究前景：以鲟鱼铁蛋白为例
Front Nutr. 2025 Jul 23;12:1656213. doi: 10.3389/fnut.2025.1656213. eCollection 2025.
4
Novel (1S,3R)-RSL3-Encapsulated Polyunsaturated Fatty Acid Rich Liposomes Sensitise Multiple Myeloma Cells to Ferroptosis-Mediated Cell Death.新型（1S,3R）-RSL3包裹的富含多不饱和脂肪酸的脂质体使多发性骨髓瘤细胞对铁死亡介导的细胞死亡敏感。
Int J Mol Sci. 2025 Jul 9;26(14):6579. doi: 10.3390/ijms26146579.
5
Iron, Hepcidin, and Immunity.铁、铁调素与免疫
Adv Exp Med Biol. 2025;1480:197-215. doi: 10.1007/978-3-031-92033-2_14.
6
Targeting ferroptosis: a novel insight into thyroid cancer therapy.靶向铁死亡：甲状腺癌治疗的新见解。
Front Endocrinol (Lausanne). 2025 Jun 3;16:1527693. doi: 10.3389/fendo.2025.1527693. eCollection 2025.
7
GATA1: A key biomarker for predicting the prognosis of patients with diffuse large B-cell lymphoma.GATA1：预测弥漫性大B细胞淋巴瘤患者预后的关键生物标志物。
Open Med (Wars). 2025 May 7;20(1):20251185. doi: 10.1515/med-2025-1185. eCollection 2025.
8
Dysregulation of miR-106a-5p/PTEN axis associated with progression and diagnostic of postmenopausal osteoporosis.miR-106a-5p/PTEN轴的失调与绝经后骨质疏松症的进展和诊断相关。
J Orthop Surg Res. 2025 May 13;20(1):456. doi: 10.1186/s13018-025-05872-3.
9
GFR is a Key Determinant of Red Blood Cell Survival in Anemia Associated With Progressive CKD.肾小球滤过率是进行性慢性肾脏病相关贫血中红细胞存活的关键决定因素。
Kidney Int Rep. 2024 Dec 21;10(3):730-742. doi: 10.1016/j.ekir.2024.12.023. eCollection 2025 Mar.
10
Cerium Interferes Iron Binding to Human Serum Apo-Transferrin Which can Affect Iron Metabolism.铈会干扰铁与人类血清脱铁转铁蛋白的结合，这可能会影响铁代谢。
Indian J Hematol Blood Transfus. 2025 Apr;41(2):257-266. doi: 10.1007/s12288-024-01850-7. Epub 2024 Sep 19.
本文引用的文献
1
Bioavailable Trace Metals in Neurological Diseases.神经疾病中的生物可利用痕量金属
Curr Treat Options Neurol. 2016 Oct;18(10):46. doi: 10.1007/s11940-016-0426-1.
2
Ironing out the cross talk between FGF23 and inflammation.理清成纤维细胞生长因子23（FGF23）与炎症之间的相互作用。
Am J Physiol Renal Physiol. 2017 Jan 1;312(1):F1-F8. doi: 10.1152/ajprenal.00359.2016. Epub 2016 Aug 31.
3
Intestinal brush-border Na+/H+ exchanger-3 drives H+-coupled iron absorption in the mouse.肠道刷状缘钠/氢交换蛋白3驱动小鼠体内氢离子偶联的铁吸收。
Am J Physiol Gastrointest Liver Physiol. 2016 Sep 1;311(3):G423-30. doi: 10.1152/ajpgi.00167.2016. Epub 2016 Jul 7.
4
Loss of Frataxin induces iron toxicity, sphingolipid synthesis, and Pdk1/Mef2 activation, leading to neurodegeneration.线粒体铁转运蛋白缺失会引发铁毒性、鞘脂合成以及丙酮酸脱氢酶激酶1/肌细胞增强因子2激活，进而导致神经退行性变。
Elife. 2016 Jun 25;5:e16043. doi: 10.7554/eLife.16043.
5
Combined iron sucrose and protoporphyrin treatment protects against ischemic and toxin-mediated acute renal failure.蔗糖铁和原卟啉联合治疗可预防缺血性和毒素介导的急性肾衰竭。
Kidney Int. 2016 Jul;90(1):67-76. doi: 10.1016/j.kint.2016.01.022. Epub 2016 Mar 24.
6
Iron and cancer: recent insights.铁与癌症：近期见解
Ann N Y Acad Sci. 2016 Mar;1368(1):149-61. doi: 10.1111/nyas.13008. Epub 2016 Feb 18.
7
Hepcidin regulation in the anemia of inflammation.炎症性贫血中的铁调素调节
Curr Opin Hematol. 2016 May;23(3):189-97. doi: 10.1097/MOH.0000000000000236.
8
Iron management in chronic kidney disease: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.慢性肾脏病中的铁管理：“改善全球肾脏病预后组织”（KDIGO）争议会议的结论。
Kidney Int. 2016 Jan;89(1):28-39. doi: 10.1016/j.kint.2015.10.002.
9
Iron and the liver.铁与肝脏
Liver Int. 2016 Jan;36 Suppl 1:116-23. doi: 10.1111/liv.13020.
10
Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production.炎症和功能性铁缺乏调节成纤维细胞生长因子23的产生。
Kidney Int. 2016 Jan;89(1):135-46. doi: 10.1038/ki.2015.290. Epub 2016 Jan 4.
Zotero 插件